GATC acquires SOLiD DNA Sequencer from Applied Biosystems
GATC Biotech announced the acquisition of a SOLiD(TM) DNA sequencing system from Applied Biosystems. The new system will be the third next generation sequencing technology to be installed in GATC's German research facility in Constance, which currently holds the GS FLX(TM) from Roche Diagnostics as well as the Genome Analyzer(TM) from Illumina.
Being a part of Applied Biosystems' Early-Access Program, the SOLiD System is expected to be installed in early autumn this year and will boost the company's current sequencing capacity from 130 gigabases to 250 gigabases a year. Therefore GATC will be the first and only commercial sequencing service provider worldwide being able to offer ultra high-throughput DNA analysis using all three leading next generation sequencing technologies. The total investment exceeds 2 million Euros.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.